Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

Sixty-six percent of <keyword id="23012810" type="General" weightage="100" keywordseo="road-traffic-deaths" source="keywords">road traffic deaths</keyword> in <keyword id="19952305" type="General" weightage="20" keywordseo="Southeast-Asia" source="keywords">Southeast Asia</keyword> are of <keyword id="20239488" type="General" weightage="20" keywordseo="pedestrians" source="keywords">pedestrians</keyword>, motorized <keyword id="20937113" type="General" weightage="20" keywordseo="two-wheeler-riders" source="keywords">two-wheeler riders</keyword>, and <keyword id="20007750" type="General" weightage="20" keywordseo="cyclists" source="keywords">cyclists</keyword>, while the highest traffic fatalities in India are among two- and three-wheeler riders, according to the latest <keyword id="20738786" type="General" weightage="20" keywordseo="WHO-report" source="keywords">WHO report</keyword>. The "WHO South-East Asia Regional Status Report on <keyword id="20187029" type="General" weightage="20" keywordseo="road-safety" source="keywords">Road Safety</keyword>" was launched during "Safety 2024", the 15th World Conference on Injury Prevention and Safety Promotion, 2024. According to the World Health Organization (WHO), globally, 30% of reported road traffic deaths involved users of powered two- and three-wheelers. Occupants of four-wheeled vehicles make up 25% of the deaths and pedestrians account for 21 %. Cyclists represent 5% of the deaths. The remaining 20% include occupants of large vehicles, heavy goods vehicles, and other or unknown user types. "In the WHO Southeast Asia Region, the share of reported road traffic deaths is 46% for users of powered two- and three-wheelers, 12 for occupants of four-wheeled vehicles, 17% for pedestrians, 3% for cyclists and 22% for others. In all these countries, vulnerable road users (pedestrians, motorised two-wheeler users and bicyclists) constitute 66% of the total reported road traffic deaths," the report said. "Drivers or riders of two and three-wheelers constitute the highest proportion among all road user categories in India (45.1%), Maldives (100 %), Myanmar (47%) and Thailand (51.4%)," it added. The WHO noted that no country in the South Asian region had achieved the target of reducing its estimated road traffic deaths by 50 %. However, considerable reduction in the WHO's estimated road traffic deaths occurred in the Maldives and Thailand, where estimated road traffic deaths decreased by 46.2% and 41.7 %, respectively. On the contrary, reported road traffic deaths in the region increased by 15 % in the 2010-2021 period. At the country level, no member state of the Southeast Asia Region with more than 10 million population has reported a decrease in road traffic deaths during this period. "However, it should be noted that the reported number of road traffic deaths in Thailand reduced by 22.9% between 2016 and 2021. The estimated road traffic deaths too increased in Bangladesh, India and Nepal during the period 2010-2021 by 23 %, 2% and 25%, respectively," the report said. Etienne Krug, director of the WHO's Department for Social Determinants of Health, said road traffic crashes were a major crisis of the 21st century. "...a large proportion of people who die in road crashes are those who cannot afford to buy a car. This is urgent time to take action. The report reveals that the crisis is huge but we need to understand and act with determination that prevention is possible and needs strict enforcement," he said. The three-day conference is being hosted by the Indian Institute of Technology (IIT), Delhi; George Institute for Global Health in collaboration with the All India Institute for Medical Sciences (AIIMS), National Institute of Mental Health and Neuro Sciences (NIMHANS) and co-sponsored by WHO. "To reduce inequities, we must acknowledge that injuries disproportionately impact vulnerable communities -- because we are far behind in addressing real problems with real solutions. Lived experience shows how policy shapes differential exposure, risk, and outcomes, underscoring the urgent need for change," said Jagnoor Jagnoor, head of injury division at George Institute for Global Health. During the conference, the international experts are uniting with a shared goal of "building a safer future for all: Equitable and sustainable strategies for injury and violence prevention". The conference will focus on five key themes -- improving coordination and collaboration among stakeholders, strengthening capacity for research and practice, integrating injury prevention with global health agendas such as sustainability and equity, empowering communities, and promoting informed policymaking.

Pedestrians, cyclists, two-wheeler riders constitute 66% of road fatalities in Southeast Asia, says a WHO report

Sydney, Aug 15 (The Conversation): The <keyword id="19896311" type="General" weightage="20" keywordseo="World-Health-Organization" source="keywords" meta.keywordsubtype="org" meta.entityname="World Health Organization" meta.hostid="261" meta.entityid="World Health Organization">World Health Organization</keyword> (<keyword id="19895006" type="General" weightage="20" keywordseo="WHO" source="keywords">WHO</keyword>) has declared <keyword id="20965747" type="General" weightage="100" keywordseo="mpox" source="keywords">mpox</keyword> a public health emergency of international concern, after rising cases in the <keyword id="22796094" type="General" weightage="20" keywordseo="Democratic-Republic-of-the-Congo" source="keywords">Democratic Republic of the Congo</keyword> and the potential for further spread. This now triggers a coordinated international response to an extraordinary event and the mobilisation of resources, such as vaccines and diagnostic testing, to curb the spread of this infectious disease. But WHO has not declared mpox a <keyword id="19913581" type="General" weightage="20" keywordseo="pandemic" source="keywords">pandemic</keyword>. Rather, the measures it has triggered are designed to prevent it from becoming one. <h2>What triggered this latest alert?</h2> Mpox, once known as monkeypox, is a viral infection closely related to <keyword id="22362924" type="General" weightage="20" keywordseo="smallpox" source="keywords">smallpox</keyword>. Initial symptoms include a fever, headache, swelling of the lymph nodes and muscle ache. A typical rash follows, mainly on the face, hands and feet. The spread of mpox through certain African countries led the Africa Centres for Disease Control and Prevention to declare earlier this week mpox a public health emergency of continental security. This is the first time the organisation has issued such an alert since it was established in 2017. The situation in the Democratic Republic of the Congo in central Africa has been particularly worrying for more than a year. There are two types or clades of mpox. Clade II, which originates in west Africa, is less severe. It has a fatality rate of up to 1 per cent (in other words, roughly one in 100 are expected to die from it). But clade I, from central Africa, has a fatality rate of up to 10 per cent (up to one in ten die). This compares to a 0.7 per cent fatality rate for the Omicron variant of SARS-CoV-2, the virus that causes COVID. The Democratic Republic of the Congo is seeing large epidemics of the more deadly clade I mpox. Mpox is endemic in some parts of central and west Africa, where the virus exists in animals and can spread to humans. Outbreaks have been increasing, with more human-to-human spread, since 2017. This is partly due to very low levels of immunity to the mpox virus, which is related to the virus that causes smallpox. Mass vaccination against smallpox ceased more than 40 years ago globally, resulting in minimal immunity in populations today against mpox. The WHO designation announced this week relates to the clade I. Not only does this have a higher fatality rate, it has new mutations that enhance spread between people. These changes, and the global lack of immunity to mpox, makes the world's population vulnerable to the virus. <h2>There are two different epidemics</h2> In 2022, an epidemic of mpox swept through non-endemic countries, including beyond Africa. This was a variant of clade II originating from Nigeria, called clade IIb. This was sexually transmitted, predominantly affecting men who have sex with men, and had a low fatality rate. That epidemic peaked in 2022, with vaccines made available to people at risk in high-income countries, but there has been an uptick in 2024. At the same time, large clade I epidemics were occurring in the Democratic Republic of the Congo, but with far less attention. Vaccines were not available there, even in 2023, when there were 14,626 cases and 654 deaths. Mortality was 4.5 per cent, and higher in children. In fact, most cases and deaths in the Democratic Republic of the Congo have been children. This means most transmission there is non-sexual and is likely to have occurred through close contact or respiratory aerosols. However, in 2023 an <keyword id="20877025" type="General" weightage="20" keywordseo="outbreak" source="keywords">outbreak</keyword> in a non-endemic part of the country, South Kivu in the east, appeared to be by sexual transmission, indicating more than one epidemic and different transmission modes in the Democratic Republic of the Congo. By mid-2024, there were already more cases in the country than all of 2023 - more than 15,600 cases and 537 deaths. Testing capacity is low in the Democratic Republic of the Congo, most cases are not confirmed by lab testing, and the data we have are from a small sample of genomic sequences from the Kamituga region of South Kivu. This show mutations to the clade I virus around September 2023, to a variant termed clade Ib, which is more readily transmissible between people. We do not have much data to compare these viruses with the viruses causing cases in the rest of the country. <h2>Mpox is spreading internationally</h2> In the past month, the virus has spread to countries that share a border with the Democratic Republic of the Congo - Rwanda and Burundi. It has also spread to other east African countries, such as Kenya and Uganda. None of these countries have had mpox cases previously. In an interconnected, mobile world, cases may spread to other continents, as mpox did in 2018 from Nigeria to the United Kingdom and other countries. A few travel-related cases between 2018 and 2019 may have led to the large multi-country 2022 clade IIb epidemic. <h2>We have vaccines, but not where they are needed</h2> As the mpox virus and smallpox viruses are related (they are both orthopoxviruses), smallpox vaccines offer protection against mpox. These vaccines were used to control the 2022 clade IIb epidemic. However, most of the world has never been vaccinated, and has no immunity to mpox. The newer <keyword id="19959412" type="General" weightage="20" keywordseo="vaccine" source="keywords">vaccine</keyword> (called Jynneos in some countries and Imvamune or Imvanex in others) is effective. However, supplies are limited, and vaccine is scarce in the Democratic Republic of the Congo. WHO's declaration of mpox as a public health emergency of international concern will help mobilise vaccines to where they are needed. The Africa Centres for Disease Control had already begun negotiations to secure 2,00,000 doses of vaccine, which is a fraction of what is required to control the epidemic in the Democratic Republic of the Congo. <h2>What happens now?</h2> Ultimately, a serious epidemic anywhere in the world is a concern for all of us, as it can spread globally through travel, as we saw with the COVID pandemic. Controlling it at the source is the best measure, and WHO's latest declaration will help mobilise the required resources. Surveillance for spread of this more serious version of mpox is also essential, bearing in mind that many countries do not have the capacity for widespread testing. So we'll have to rely on "suspected cases", based on a clinical definition, to keep track of the epidemic. Open-source epidemic intelligence - such as using AI to monitor trends in rash and fever illness - can also be used as an early warning system in countries with weak health systems or delayed reporting of cases. A further complication is that 20-30 per cent of people with mpox may simultaneously have chickenpox, an unrelated infection that also causes a rash. So an initial diagnosis of chickenpox (which is easier to test for) does not rule out mpox. Effective communication and tackling push-back against public health measures and disinformation is also key. We saw how important this was during the COVID pandemic. Now, WHO will coordinate the global mpox response, focusing on equity in disease prevention and access to diagnostics and vaccines. It is up to individual countries to do their best to comply with the International Health Regulations, and the protocols for how such a global emergency are managed.

WHO has declared mpox a global health emergency. What happens next?

The World Health Organisation (<keyword id="19895006" type="General" weightage="20" keywordseo="WHO" source="keywords">WHO</keyword>) has announced that <keyword id="22989608" type="General" weightage="100" keywordseo="M-Pox" source="keywords">M-Pox</keyword> will continue to be classified as a <keyword id="21952478" type="General" weightage="20" keywordseo="public-health-emergency" source="keywords">public health emergency</keyword> of international concern (PHEIC), citing a resurgence in cases and the virus's ongoing geographic spread. The high-alert status initially declared in August, was reaffirmed following a meeting of the WHO Emergency Committee, The Express Tribune reported on Friday. The decision comes as M-Pox cases surge, particularly with the spread of the <keyword id="22875864" type="General" weightage="20" keywordseo="clade-Ib-variant" source="keywords">clade Ib variant</keyword> beyond its origin in the Democratic Republic of Congo to neighbouring African nations, Europe, and Asia. "Rising case numbers, the continuing geographic spread, and the need for a cohesive response have made it essential to maintain this emergency status," the WHO said in its statement. Confirmed cases of clade Ib have been detected in the United Kingdom, Germany, Sweden, and India, highlighting the global scale of the outbreak, reported The Express Tribune. M-Pox, a viral disease transmitted through close contact, presents flu-like symptoms and lesions. Although typically mild, it can be fatal, particularly in regions with inadequate healthcare. Over 46,000 suspected cases have been reported this year in Africa, with Congo accounting for the majority of the more than 1,000 suspected deaths. The new PHEIC declaration underscores the global threat posed by clade Ib and follows earlier alerts related to a separate strain during the 2022-2023 outbreak. In response to growing concerns, the WHO has expanded vaccine authorisations. Bavarian Nordic's <keyword id="24137585" type="General" weightage="20" keywordseo="M-Pox-vaccine" source="keywords">M-Pox vaccine</keyword> was approved earlier this year, with Japan's KM Biologics' vaccine added to the list of emergency-use vaccines in September. WHO officials have faced criticism for delays in <keyword id="21847727" type="General" weightage="20" keywordseo="vaccine-distribution" source="keywords">vaccine distribution</keyword> but stressed that vaccination remains a cornerstone of global response efforts, The Express Tribune reported. "The emergency status underscores the urgency to mount a unified global response," a WHO spokesperson stated. The organisation urged countries and health partners to collaborate on widespread vaccination campaigns and enhance public awareness to curb the virus's spread effectively.

M-Pox remains public health emergency: WHO

The number of <keyword id="19933600" type="General" weightage="100" keywordseo="prostate-cancer" source="keywords">prostate cancer</keyword> cases is rising among men aged below 50 years in India, with a more aggressive form of the disease, experts have said, underscoring that it can be managed effectively if identified early as it often grows slowly. September is recognised as Prostate <keyword id="23363213" type="General" weightage="20" keywordseo="cancer-awareness-month" source="keywords">Cancer Awareness Month</keyword> for raising awareness about one of the most common cancers affecting men worldwide. Prostate cancer, which develops in the prostate gland, primarily affects older men, but it is on the rise in younger men in India, with a more aggressive form of the disease, according to the experts. The incidence of prostate cancer in the under-50 age group has increased significantly, they have pointed out. According to the <keyword id="19896311" type="General" weightage="20" keywordseo="World-Health-Organization" source="keywords" meta.keywordsubtype="org" meta.entityname="World Health Organization" meta.hostid="266" meta.entityid="World Health Organization">World Health Organization</keyword>'s (WHO) figures, prostate cancer affected 37,948 Indian men -- accounting for roughly 3% of the 14 lakh new cancer cases registered in the country -- in 2022. Dr Ashish Gupta, a medical oncologist certified by the American board and the chief of the medical oncology department at the Unique Hospital Cancer Centre in Delhi, said, "<keyword id="20123436" type="General" weightage="20" keywordseo="early-detection" source="keywords">Early detection</keyword> significantly increases the survival rates as prostate cancer is often slow-growing and can be managed effectively if identified in the initial stages." "The biggest issue in India is late diagnosis," he added. In the United States, 80% of prostate cancer patients are diagnosed early and 20% report it late, Gupta said, adding that the statistics are reversed in India. Through regular PSA tests and check-ups, men can take control of their health and reduce the chances of the disease advancing, he said. Although symptoms are often absent in the early stages, men should be aware of the potential warning signs, including difficulty in urinating, frequent urination (especially at night), blood in the urine or semen and pain in the hips, back or pelvis, he said. The experts have warned against a delay in diagnosis and treatment, given that it can prove to be fatal. Most often, the symptoms of prostate cancer are either ignored or neglected, leading to advanced stages of the disease. "We are observing a rise in prostate cancer cases in young adults, which was earlier associated with adults aged above 50 years. Cancer reports among younger males aged 35 to 44 residing in metropolitan regions have recently increased," Gupta said. Advances in medical technology, including robotic surgeries and precision radiation, have significantly improved the prognosis for prostate cancer patients. However, the fear of being diagnosed, combined with societal pressures on men to stay silent about health issues, prevents many from seeking timely medical advice. Modern treatment methods like immunotherapy, targeted therapy and a combination of radiation therapy and chemotherapy are proving to be an effective treatment option and giving a new lease of life to prostate cancer patients, Gupta said. Dr Tanvi Sood, a medical oncologist at the Paras Hospital in Gurugram, said, "Prostate cancer is increasing in young men around the globe. It is known to be more aggressive in nature and usually diagnosed at an advanced stage. Increased screening may have contributed to increased diagnosis in younger men. However, there could also be a hereditary genetic syndrome causing prostate cancer in the men in a family." Timely diagnosis can help start the right treatment like surgery, hormonal therapy, radiation therapy, chemotherapy, targeted therapy and immunotherapy. It is very important to check for hereditary genetic mutations in all prostate cancer patients, especially young patients, Sood underlined. Gupta concluded that men with a family history of prostate cancer are at a higher risk, especially if someone's father, brother or uncle was diagnosed with the disease. Genetic factors play a role, so those with a family history should consider earlier and more frequent screenings, he added. Healthy lifestyle habits can help reduce the risk of developing prostate cancer. A diet rich in fruits, vegetables and whole grains, along with regular physical activity, can support prostate health. Reducing red meat and fat intake, along with avoiding smoking, can also help lower the risk, Gupta said. By staying informed, opting for regular screenings and following healthy lifestyle choices, men can significantly reduce the risks associated with prostate cancer, he added.

Prostate cancer cases rising among men aged below 50 in India, note experts

Ozempic explained: Key insights on the trending medication

The <keyword id="22667872" type="General" weightage="100" keywordseo="mpox-outbreak" source="keywords">mpox outbreak</keyword> in <keyword id="19924003" type="General" weightage="20" keywordseo="africa" source="keywords">Africa</keyword> is yet another example of how <keyword id="20040661" type="General" weightage="20" keywordseo="infectious-diseases" source="keywords">infectious diseases</keyword>, perceived to be "someone else's problem", and affecting mainly poor, developing countries, may suddenly pose unexpected global threats. Other examples of <keyword id="22817243" type="General" weightage="20" keywordseo="neglected-diseases" source="keywords">neglected diseases</keyword> include the West Nile, Zika and Chikungunya viruses. Mpox was discovered in 1958 (in captive monkeys, hence the original misnomer "monkeypox") and the first human case was identified in 1970. Then, for decades it was largely neglected by the scientific and public health communities, regarded as an uncommon infection in remote rural areas in tropical Africa, without relevance for the rest of the world. When a massive mpox outbreak hit developed countries in 2022, increased research funding led to a surge in scientific studies. On just one medical search engine, there's been more research produced since April 2022 than in the preceding 60 years. The 2022-23 global mpox outbreak happened despite repeated calls from African researchers for increased global investment in diagnostic, therapeutic and infection prevention tools for mpox. The WHO has now declared the current upsurge of mpox in central Africa a <keyword id="21952478" type="General" weightage="20" keywordseo="public-health-emergency" source="keywords">public health emergency</keyword> of international concern. This is the highest alert level for events that constitute a public health risk to other countries and requires a coordinated international response. Mpox's recent history is yet another reminder that an infectious disease in one corner of the world should not be regarded as someone else's problem, as it can suddenly start to spread fast and far. It also highlights global inequities in resource allocation and access to vaccines, diagnostics and treatments. These were made available in many industrialised countries and helped curb the global outbreak, but are still largely lacking in most of Africa. <h2>The 2022 outbreak: a total surprise</h2>The disease has been renamed "mpox" but the name of the virus, for now, remains "monkeypox" (MPXV). It is closely related to the smallpox virus. MPXV was considered a <keyword id="21311828" type="General" weightage="20" keywordseo="zoonotic-disease" source="keywords">zoonotic disease</keyword> endemic in parts of central and west Africa. It was acquired mainly through close contact with wild mammals, especially handling bush meat, but there was no sustained human-to-human transmission. Only very occasionally were cases seen outside the endemic areas, due to infected travellers or import of infected small mammals. This changed abruptly in 2022: a massive, rapidly evolving global outbreak caused over 99,000 laboratory-confirmed cases in 116 countries. At its peak in August 2022, over 6,000 cases were reported each week. This outbreak came as a total surprise: most cases were reported from non-endemic countries, mostly in men who have sex with men, who had become infected during recent sexual encounters. Even though most cases were clinically not particularly severe and the death toll stands at just over 200, the global outbreak was declared a public health emergency of international concern by the <keyword id="19896311" type="General" weightage="20" keywordseo="world-health-organization" source="keywords">World Health Organization</keyword> on 23 July, 2022. Fortunately, case numbers soon plummeted due to a combination of behavioural changes and vaccination in at-risk groups. Modern vaccines and antiviral drugs with activity against mpox were made available in many affected high-income countries. These had been developed and stockpiled in the US and Europe, mostly in preparation for a potential bioweapon attack using a poxvirus. The global outbreak in 2022 was caused by clade II of MPXV, which is endemic in west Africa and not as virulent as clade I MPXV, which so far has only been seen in the Congo Basin. That first mpox public health emergency of international concern was declared over in May 2023. Clade II MPXV infections are still occurring globally, but the worst seems over - for now. Complacency would be misguided, as illustrated by the current mpox outbreak that is gathering steam. <h2>Upsurge in Africa</h2>The African region is experiencing an upsurge in mpox cases, which started in 2023. As the continent which includes the areas where mpox has been endemic for a long time, Africa now presents a complex mosaic. The current clade I MPXV (formerly called Congo Basin strain) is more virulent than the clade II (west African) strain, resulting in a higher case fatality rate. The ongoing outbreak has its epicentre in South Kivu province, eastern DRC, and has the potential to fuel a large pandemic. It has a distinct epidemiological pattern with sustained chains of human-to-human transmission, often via the sexual route. It may have increased transmissibility (we don't know yet). The virus which causes it is the newly defined clade Ib lineage. It displays mutations that are the hallmark of human-to-human spread that is estimated to have been happening since September 2023. Case numbers are rising rapidly, even though many suspected cases are likely not tested and thus not counted as confirmed. Complicating matters, a commonly used test was found to miss infections with this lineage of the virus. It affects mostly adults. The case fatality rate is higher than it was in the 2022 global outbreak. Already, this outbreak has resulted in mpox cases occurring in several neighbouring countries, including some (like Kenya), with no previous record of mpox. The challenge is enormous. The eastern DRC is an area beset by multiple problems. This includes natural disasters, violence and infectious diseases including measles, cholera and poliomyelitis for the DRC. In recent years the second-largest Ebola outbreak ever took place in the wider area and, despite the availability of vaccines and treatments, posed considerable challenges. <h2>What needs to happen</h2>Equitable access to diagnostic tests, vaccines and antiviral treatments requires political commitment and financial investments. Scientific investigations are needed to learn more about exposure settings, transmission routes and clinical presentations. It's important to find the best ways to make these interventions. There is no doubt that a disease in one corner of the world can suddenly become a global heath threat. It's time the global health system woke up to this reality.

Mpox outbreak in Africa was neglected - it could now turn into the next global pandemic

All Indian <keyword id="19926225" type="General" weightage="20" keywordseo="salt" source="keywords">salt</keyword> and <keyword id="20109149" type="General" weightage="20" keywordseo="sugar" source="keywords">sugar</keyword> brands, whether big or small, packaged or unpackaged, contain <keyword id="19970180" type="General" weightage="100" keywordseo="microplastics" source="keywords">microplastics</keyword>, according to a study published on Tuesday. The study, titled "Microplastics in Salt and Sugar" and conducted by the <keyword id="22774411" type="General" weightage="20" keywordseo="environmental-research-organisation" source="keywords">environmental research organisation</keyword> <keyword id="21593811" type="General" weightage="20" keywordseo="Toxics-Link" source="keywords" meta.keywordsubtype="org" meta.entityname="Toxics Link" meta.hostid="281" meta.entityid="Toxics Link">Toxics Link</keyword>, tested 10 types of salt -- including table salt, rock salt, <keyword id="158885" type="General" weightage="20" keywordseo="sea-salt" source="Orion">sea salt</keyword> and local raw salt -- and five types of sugar purchased from both online and local markets. The study revealed the presence of microplastics in all salt and sugar samples, in various forms, including fibre, pellets, films and fragments. The size of these microplastics ranged from 0.1 mm to 5 mm. The highest levels of microplastics were found in <keyword id="630077" type="General" weightage="20" keywordseo="iodised-salt" source="Orion">iodised salt</keyword>, in the form of multi-coloured thin fibre and films. Toxics Link founder-director Ravi Agarwal said, "The objective of our study was to contribute to the existing scientific database on microplastics, so that the global plastic treaty can address this issue in a concrete and focused manner." "We also aim to trigger policy action and attract researchers' attention to potential technological interventions that could reduce exposure risks to microplastics." Toxics Link associate director Satish Sinha added, "Our study's finding of substantial amounts of microplastics in all salt and sugar samples is concerning and calls for urgent, comprehensive research into the long-term health impacts of microplastics on human health." The concentration of microplastics in the salt samples ranged from 6.71 to 89.15 pieces per kilogramme of dry weight, the report said. Iodised salt had the highest concentration of microplastics (89.15 pieces per kilogramme) while organic rock salt had the lowest (6.70 pieces per kilogramme), according to the study. In sugar samples, the concentration of microplastics ranged from 11.85 to 68.25 pieces per kilogramme, with the highest concentration found in non-organic sugar. Microplastics are a growing global concern because they can harm both health and the environment. These tiny plastic particles can enter the human body through food, water and air. Recent research has found microplastics in human organs such as the lungs, heart, and even in breast milk and unborn babies. Previous studies found that the average Indian consumes 10.98 grams of salt and around 10 spoons of sugar every day -- much higher than the <keyword id="19896311" type="General" weightage="20" keywordseo="world-health-organization" source="keywords">World Health Organization</keyword>'s recommended limits.

All Indian salt and sugar brands have microplastics, notes a recent study

Discussions around <keyword id="19956983" type="General" weightage="20" keywordseo="mental-health" source="keywords">mental health</keyword> at the workplace reignited in the last few days when the death of two corporate employees made headlines. And it is no secret that without having a healthy mind, you cannot be productive. Ample studies in the last few months have pointed out the importance of mental health and it is important to talk about these issues. Today (October 10) marks <keyword id="23481940" type="General" weightage="20" keywordseo="World-Mental-Health-Day" source="keywords">World Mental Health day</keyword>. It is an occasion for raising awareness about mental health issues and combating social stigma. Celebrated globally since 1992, this day encourages education and advocacy for mental well-being, reminding us that mental health is a crucial aspect of overall health, especially in the workplace. <h2>Ex-Google employee experienced stress, anxiety </h2> <keyword id="23300967" type="General" weightage="20" keywordseo="Nicholas-Whitaker" source="keywords">Nicholas Whitaker</keyword>, who worked with <keyword id="19902762" type="General" weightage="100" keywordseo="Google" source="keywords" meta.keywordsubtype="org" meta.entityname="Google" meta.hostid="261" meta.entityid="Google">Google</keyword> for 13 years, told Business Insider India in an interview that he also experienced the pressures of a high-stress work environment. “During my time at Google, I faced significant stress and anxiety. It became clear that no matter how successful you are on paper, if your mental health is compromised, it diminishes your quality of life and ability to fully engage at work,” he said. He added that <keyword id="19925554" type="General" weightage="20" keywordseo="mindfulness" source="keywords">mindfulness</keyword> played a crucial role in his recovery, saying that mental health is not just a personal issue but a workplace concern that should be treated with equal importance as productivity and performance. <h2>How to protect your mental health? </h2> To help others protect their mental health, Whitaker shared several key practices that can be game-changers. 1. Set Boundaries: Understand your limits and communicate them clearly. This includes managing your workload, taking time away from work, and setting boundaries around communication. Protecting your time and energy is essential. 2. Practice Mindfulness or Meditation: Mindfulness was a lifesaver for him in managing corporate stress. Even dedicating a few minutes each day to meditation can help you stay grounded and aware of your feelings, allowing you to make necessary adjustments before burnout sets in. 3. Take Breaks: In high-pressure environments, it’s easy to feel that there’s no time for a break. However, regular breaks—even just a short walk or stepping outside—can significantly enhance your mental state and boost productivity. 4. Find a Support System: Having people to talk to, whether colleagues, friends, or coaches, can make a considerable difference. Building a supportive community can combat feelings of isolation, which often exacerbate mental health issues. 5. Align Work with Values: Stress and dissatisfaction often arise from a misalignment between personal values and work. Reflecting on what truly matters to you and making small shifts toward work that aligns with those values can lead to greater fulfillment. To conclude, Whitaker said, “Mental health is not a luxury—it’s essential for personal well-being and professional success. When organisations invest in their employees’ mental health, they cultivate a culture where people feel supported, valued, and empowered to excel in their work.” As we observe <keyword id="23486492" type="General" weightage="20" keywordseo="world-mental-health" source="keywords">World Mental Health</keyword> Day, it’s crucial to remember that prioritising mental well-being can lead to a more productive, innovative, and fulfilled workforce.

You Searched For "world health organization who" and got 8 results

Pedestrians, cyclists, two-wheeler riders constitute 66% of road fatalities in Southeast Asia, says a WHO report

PTI

WHO has declared mpox a global health emergency. What happens next?

PTI

M-Pox remains public health emergency: WHO

ANI

Prostate cancer cases rising among men aged below 50 in India, note experts

PTI

Ozempic explained: Key insights on the trending medication

Kapil Yadav

Mpox outbreak in Africa was neglected - it could now turn into the next global pandemic

PTI

All Indian salt and sugar brands have microplastics, notes a recent study

PTI

World Mental Health Day: Ex-Google employee shares tips on protecting mental health at workplace, says he experienced stress and anxiety

Divyanshi Sharma

Popular Keywords

Buying Guides